Vanguard Group’s Avanir Pharmaceuticals AVNR Stock Holding History
Bought
Maintained
Sold
Vanguard Group's AVNR Position: Q1 2015 in Review
Vanguard Group sold out of Avanir Pharmaceuticals (AVNR) in Q1 2015, closing a stake of 8,989,968 shares — an estimated $152M sold.
Vanguard Group first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $152M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.
- Vanguard Group reported no remaining Avanir Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
- Vanguard Group sold 8,989,968 Avanir Pharmaceuticals shares in Q1 2015, an estimated $152M.
- Vanguard Group first reported a position in Avanir Pharmaceuticals in Q2 2013 and held it in 7 quarters.
- Vanguard Group's Avanir Pharmaceuticals position peaked at $152M in Q4 2014.
- 0 funds tracked by Wall St. Rank held Avanir Pharmaceuticals as of Q1 2015.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.